Keros Therapeutics KROS
NASDAQ KROS
$11.38 +0.20 (+1.79%)
As of: Oct 22, 2026 · 10:11 AM EDT

Keros Therapeutics (KROS) Treasury Shares (2025 - 2026)

Updated

Keros Therapeutics' Treasury Shares came in at $384.56 million for Q2 2026.

Analysis

Keros Therapeutics (KROS) Treasury Shares (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,164.86 Bn 1,133.45 Bn 19.71 Bn -
2 Johnson & Johnson 632.18 Bn 550.71 Bn 17.26 Bn 711.62 Mn
3 AbbVie 503.53 Bn 476.64 Bn 12.70 Bn 77.11 Mn
4 Merck 378.03 Bn 332.41 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 303.09 Bn 267.08 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 266.38 Bn 240.07 Bn 12.86 Bn -
7 Amgen 241.24 Bn 196.64 Bn 7.24 Bn -
8 Gilead Sciences 193.68 Bn 167.88 Bn 6.22 Bn -
9 Pfizer 172.22 Bn 118.87 Bn 10.94 Bn 3.94 Bn
10 Keros Therapeutics 222.95 Mn -1.71 Bn - 21.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.13 Mn
Dec 31, 2025 21.13 Mn
API Access

Keros Therapeutics Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=KROS&period=max&api_key=YOUR_API_KEY